Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Regulatory News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Price Monitoring Extension

25 Apr 2018 09:00

RNS Number : 0630M
Redx Pharma plc
25 April 2018
 

Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PMEUVRWRWRASURR
Date   Source Headline
13th Apr 201612:06 pmRNSResult of General Meeting and Issue of Equity
4th Apr 20162:58 pmRNSGrant of Options
4th Apr 201612:59 pmRNSResult of General Meeting
4th Apr 20167:00 amRNSIssue of Equity
29th Mar 20167:00 amRNSDirector/PDMR Shareholding
24th Mar 20161:55 pmRNSPlacing to Raise £10 Million
8th Mar 20167:00 amRNSChange of Adviser
24th Feb 201612:39 pmRNSResult of AGM
24th Feb 20167:00 amRNSAGM Statement
22nd Jan 20169:09 amRNSHardman & Co Research Report: Pipeline progress
22nd Jan 20167:30 amRNSHardman & Co Research Report: Pipeline progress
20th Jan 20167:00 amRNSFinal Results
6th Jan 20167:00 amRNSNotice of Results
4th Jan 20167:00 amRNSAppointment of Non-Executive Director
3rd Dec 20157:00 amRNSFourth drug development candidate
10th Nov 20157:00 amRNSRe BioInfect Conference 2015
5th Nov 20157:00 amRNSSenior management appointments
23rd Oct 20152:57 pmRNSRe Review on Antimicrobial Resistance
1st Oct 20157:00 amRNSTrading Update
3rd Sep 20157:00 amRNSCancer Research Collaboration with Redx Pharma
3rd Sep 20157:00 amRNSCancer Research Collaboration
22nd Jun 20157:00 amRNSHalf Yearly Report
19th Jun 20155:14 pmRNSHolding(s) in Company
4th Jun 20159:45 amRNSHolding(s) in Company
2nd Jun 20157:00 amRNSDiscovery of breakthrough MRSA compound
26th May 20157:01 amRNSSecond drug development candidate identified
14th May 20157:00 amRNSRe Review on Antimicrobial Resistance
14th May 20157:00 amRNSLaunch of third subsidiary, Redx Immunology
11th May 20157:00 amRNSPre-Clinical Proof of Concept with Oncology Lead
31st Mar 20155:13 pmRNSHolding(s) in Company
31st Mar 20151:35 pmRNSHolding(s) in Company
31st Mar 20151:33 pmRNSHolding(s) in Company
31st Mar 20159:37 amRNSHolding(s) in Company
27th Mar 20157:00 amRNSAdmission to AIM and First Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.